Lobular carcinoma in situ and infiltrating ductal carcinoma: Frequent presence of DCIS as a precursor lesion

International Journal of Surgical Pathology

Volumn 9, Issue 2, 2001, Pages 127-131

  Maluf, Horacio ^a   Koerner, Frederick ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ductal carcinoma in situ; E cadherin; Infiltrating ductal carcinoma; Lobular carcinoma in situ; Tubular carcinoma

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER LOCALIZATION; CARCINOMA IN SITU; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFILTRATING DUCTAL CARCINOMA; PRECURSOR; PRIORITY JOURNAL;

EID: 0034930973     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690100900206     Document Type: Article

References (30)

1. Chapter 12. In situ carcinomas of the breast: Ductal carcinoma in situ, Paget's disease, lobular carcinoma in situ
2. Chapter 26. Lobular carcinoma in situ
3. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit
4. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study
5. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study
6. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
7. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
8. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
9. Chapter 35. Lobular carcinoma in situ and atypical lobular hyperplasia
10. Coexisting lobular neoplasia and carcinoma of the breast
11. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Five-year observations concerning lobular carcinoma in situ
12. Lobular neoplasia. Long-term risk of breast cancer and relation to other factors
13. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction
14. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast
15. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics
16. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
17. Chromosome alterations and E-cadherin gene mutations in human lobular cancer
18. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis
19. Epithelial-cadherin gene is not mutated in ductal carcinoma of the breast
20. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma
21. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma
22. Lobular carcinoma in situ with microinvasion
23. Loss of heterozygosity in lobular carcinoma in situ of the breast
24. Atypical lobular hyperplasia and lobular carcinoma in situ: Surgical and molecular pathology
25. Lobular neoplasia of the breast. Higher risk for subsequent invasive cancer predicted by more extensive disease
26. A comparative study of pure tubular and tubulolobular carcinoma of the breast
27. Tubulolobular invasive breast cancer: A variant of lobular invasive cancer
28. Lobular carcinoma of the breast in situ and infiltrative
29. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years
30. Risk of invasive carcinoma in women with lobular carcinoma in situ of the breast